ArticleFrontiers in endocrinology2021

Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Lidia Cerquetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.